- Home
- MDGL vs LUMN Comparison
MDGL vs LUMN Comparison
Compare MDGL & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- LUMN
- Stock Information
- Founded
- MDGL 2011
- LUMN 1968
- Country
- MDGL United States
- LUMN United States
- Employees
- MDGL N/A
- LUMN N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- LUMN Telecommunications Equipment
- Sector
- MDGL Health Care
- LUMN Telecommunications
- Exchange
- MDGL Nasdaq
- LUMN Nasdaq
- Market Cap
- MDGL 6.1B
- LUMN 5.1B
- IPO Year
- MDGL N/A
- LUMN 1972
- Fundamental
- Price
- MDGL $440.75
- LUMN $5.76
- Analyst Decision
- MDGL Strong Buy
- LUMN Buy
- Analyst Count
- MDGL 10
- LUMN 7
- Target Price
- MDGL $474.67
- LUMN $5.12
- AVG Volume (30 Days)
- MDGL 341.0K
- LUMN 16.5M
- Earning Date
- MDGL 10-30-2025
- LUMN 11-04-2025
- Dividend Yield
- MDGL N/A
- LUMN N/A
- EPS Growth
- MDGL N/A
- LUMN N/A
- EPS
- MDGL N/A
- LUMN N/A
- Revenue
- MDGL $515,547,000.00
- LUMN $12,824,000,000.00
- Revenue This Year
- MDGL $394.12
- LUMN N/A
- Revenue Next Year
- MDGL $57.74
- LUMN N/A
- P/E Ratio
- MDGL N/A
- LUMN N/A
- Revenue Growth
- MDGL 3421.98
- LUMN N/A
- 52 Week Low
- MDGL $200.63
- LUMN $3.01
- 52 Week High
- MDGL $457.16
- LUMN $10.33
- Technical
- Relative Strength Index (RSI)
- MDGL 62.88
- LUMN 62.15
- Support Level
- MDGL $415.53
- LUMN $5.45
- Resistance Level
- MDGL $440.90
- LUMN $5.99
- Average True Range (ATR)
- MDGL 14.27
- LUMN 0.42
- MACD
- MDGL -4.71
- LUMN 0.03
- Stochastic Oscillator
- MDGL 60.58
- LUMN 57.21
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About LUMN Lumen Technologies Inc.
With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.